<- Go Home
Daewoong Pharmaceutical Co., Ltd
Daewoong Pharmaceutical Co., Ltd. develops, manufactures and commercializes pharmaceutical products in South Korea and internationally. It offers products in therapeutic areas, such as central nervous system, endocrinology, musculoskeletal, nephrology, antineoplastic, cardiovascular, gastrointestinal, metabolic, antiviral, analgesic, antacid, and digestive diseases, as well as wound, iron supplements, and muti-vitamins. The company also provides COVID-19 PCR kit, COVID-19 IgG/IgM RDT, and viral transport medium medical devices. The company was founded in 1945 and is headquartered in Seoul, South Korea.
Market Cap
KRW 1.2T
Volume
41.4K
Cash and Equivalents
KRW 154.7B
EBITDA
KRW 256.8B
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
KRW 854.6B
Profit Margin
52.26%
52 Week High
KRW 199.4K
52 Week Low
KRW 104.9K
Dividend
N/A
Price / Book Value
1.17
Price / Earnings
6.39
Price / Tangible Book Value
1.86
Enterprise Value
KRW 2.1T
Enterprise Value / EBITDA
7.45
Operating Income
KRW 189.2B
Return on Equity
16.64%
Return on Assets
5.09
Cash and Short Term Investments
KRW 158.4B
Debt
KRW 925.0B
Equity
KRW 1.2T
Revenue
KRW 1.6T
Unlevered FCF
-KRW 165.6B
Sector
Pharmaceuticals
Category
N/A